Loading clinical trials...
Loading clinical trials...
Mesh Stents Study in Iliac Complex Lesions Iliac-Mesh Stent Study (IMS-Study)
The main objective of the IMS-Study is to evaluate the short and long-term safety and efficacy of mesh stent implantation in patients with stenotic iliac disease with complex plaques or lesions containing thrombotic material.
Iliac artery disease may include complex lesions with a vulnerable plaque and containing thrombotic materials. The treatment of these complex plaques is frequently complicated with local, acute occlusion, dissection and distal embolisation. Studies with a mesh stent in the carotid region have shown a reduced risk of peripheral embolization. The use of mesh stents in iliac arteries can provide similar benefits. The structure of the stents, sizes, and the release system do not require any changes. The study is to assess the usefulness of mesh stents in preventing peripheral embolisation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Medical Universtity of Warsaw
Warsaw, Masovian Voivodeship, Poland
Start Date
June 10, 2022
Primary Completion Date
October 31, 2024
Completion Date
December 31, 2024
Last Updated
May 17, 2022
50
ESTIMATED participants
Iliac Stenting
DEVICE
Lead Sponsor
Medical University of Warsaw
NCT07472049
NCT07161583
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07322913